EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Lauric acid attenuates 14-day DDC-induced cholangiopathy in association with reduced NF-κB-CCL2 signaling and restored LRH-1-regulated gene expression

Swati Ghosh, Michael W Devereaux, Colin C Anderson, David J Orlicky, Ronald J Sokol

World Journal of Gastroenterology · 2027-01-14 · 33 (2)

DOI: 10.3748/wjg.125044 ↗
AbstractBibliografische Angaben

Abstract

BACKGROUND Chronic inflammatory cholangiopathies involve bile duct injury, biochemical cholestasis, hepatocellular injury, immune cell recruitment, oxidative stress, and fibrogenic remodeling. We previously demonstrated that 20% dietary lauric acid (LA) protected against early 3,5-diethoxycarbonyl-1,4-dihydrocollidine (DDC)-induced cholangiopathy (proof of concept) by activating liver receptor homolog-1 (LRH-1). AIM To determine whether concurrent low-dose 5% dietary LA supplementation attenuates 14-day DDC-induced cholangiopathy and to characterize the associated inflammatory and metabolic responses. METHODS Eight-week-old male C57BL/6J mice were fed for 14 days with either Chow, 0.1% DDC, 5% LA, or a 0.1% DDC diet supplemented with 5% LA. RESULTS DDC feeding induced severe hepatocellular and cholestatic liver injury, macrophage infiltration, ductular reaction, oxidative stress, hepatocyte senescence, and fibrogenic remodeling. LA supplementation significantly reduced DDC-induced elevations of serum aminotransferases, bilirubin, and total bile acids, and decreased hepatic F4/80-positive macrophage infiltration and Picrosirius red collagen staining. LA supplementation restored hepatic expression of LRH-1-dependent genes involved in bile acid homeostasis, which DDC suppressed. Furthermore, DDC suppressed ileal farnesoid X receptor-fibroblast growth factor 15 signaling, which LA normalized, and LA attenuated DDC-induced hepatic oxidative and nitrosative stress and improved the expression of mitochondrial fatty acid metabolism genes. LA was associated with suppressed hepatic fibrosis markers and promoted anti-inflammatory macrophage genetic signatures. Notably, DDC activated nuclear factor-kappa B binding to the C-C motif chemokine ligand 2 promoter and repressed LRH-1 transcription, which were reversed by LA supplementation. CONCLUSION Dietary LA attenuated chronic DDC cholangiopathy which was associated with reduced nuclear factor-kappa B-dependent inflammatory signaling and restoring LRH-1-mediated bile acid homeostasis. This positions LA as a potential therapeutic strategy for inflammatory cholangiopathy.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →